|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 600 New Hampshire Ave, NW |
Address2 | Suite 1000 |
City | Washington |
State | DC |
Zip Code | 20037 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 44812-672
|
||||||||
|
6. House ID# 315070040
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Mark Isakowitz, President |
Date | 10/20/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Information Technology
S.1693: Wired for Health Care Quality Act
H.R. 6357: PRO(TECH)T Act of 2008
H.R. 6898: Health-e Information Technology Act of 2008
H.R. 4911: Human Growth Hormone Restriction Act of 2007
S. 877: Controlling the Abuse of Prescriptions Act of 2007
17. House(s) of Congress and Federal agencies Check if None
House of Representatives, Senate
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Isakowitz |
|
|
|
Kirk |
Blalock |
|
|
|
Kirsten |
Chadwick |
|
|
|
Mike |
Chappell |
|
|
|
Katie |
Huffard |
|
|
|
Kate |
Hull |
|
|
|
Samantha |
Cook |
|
|
|
Aleix |
Jarvis |
|
|
|
Don |
Fierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Genetic nondiscrimination: H.R.493/S.358: Genetic Information Nondiscrimination Act
Generic Drugs and Biologics
H.R.1038/S.623: Access to Life Saving Medicine Act
S.1695: Biologics Price Competition and Innovation Act
S.1088: Lower Priced Drugs Act; H.R.5629: The Pathway for Biosimilars Act
State generic substitution low carve outs
17. House(s) of Congress and Federal agencies Check if None
, House of Representatives, Senate, Health & Human Services, Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Isakowitz |
|
|
|
Kirk |
Blalock |
|
|
|
Kirsten |
Chadwick |
|
|
|
Mike |
Chappell |
|
|
|
Katie |
Huffard |
|
|
|
Kate |
Hull |
|
|
|
Samantha |
Cook |
|
|
|
Aleix |
Jarvis |
|
|
|
Don |
Fierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Antitrust
H.R.971/S.885: Community Pharmacy Fairness Act of 2007
S.2161: Community Pharmacy Fairness Act of 2007
Pharmacy Reimbursement
H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act
S.1954: Pharmacy Access Improvement Act of 2007
Medicare Part B
H.R.2914/S.2990: medicare IVIG Access Act
Medicare Competitive Bidding
H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act
E-Prescribing
S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Physician SGR Fix
H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act
17. House(s) of Congress and Federal agencies Check if None
, House of Representatives, Senate, Health & Human Services, Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Isakowitz |
|
|
|
Kirk |
Blalock |
|
|
|
Kirsten |
Chadwick |
|
|
|
Mike |
Chappell |
|
|
|
Katie |
Huffard |
|
|
|
Kate |
Hull |
|
|
|
Samantha |
Cook |
|
|
|
Aleix |
Jarvis |
|
|
|
Don |
Fierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Health Information Technology
S.1693: Wired for Health Care Quality Act
H.R. 6357: PRO(TECH)T Act of 2008
H.R. 6898: Health-e Information Technology Act of 2008
Anti-trust
H.R.971/S.2161: Community Pharmacy Fairness Act
Pharmacy Reimbursement
H.R.1474: Fair and Speedy Treatment of Medicare Drug Claims Act
S.1954: Pharmacy Access Improvement Act of 2007
H.R. 6353: Ryan Haight Online Pharmacy Consumer Protection Act of 2008
17. House(s) of Congress and Federal agencies Check if None
House of Representatives, Senate, Health & Human Services, Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Isakowitz |
|
|
|
Kirk |
Blalock |
|
|
|
Kirsten |
Chadwick |
|
|
|
Mike |
Chappell |
|
|
|
Katie |
Huffard |
|
|
|
Kate |
Hull |
|
|
|
Samantha |
Cook |
|
|
|
Aleix |
Jarvis |
|
|
|
Don |
Fierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |